Non-coding RNAs (ncRNAs) are emerging players in muscle regulation. Based on their length and differences in molecular structure, ncRNAs are subdivided into several categories including small interfering RNAs, stable non-coding RNAs, microRNAs (miRs), long non-coding RNAs (lncRNAs), and circular RNAs. miRs and lncRNAs are able to post-transcriptionally regulate many genes and bring into play several traits simultaneously due to a myriad of different targets. Recent studies have emphasized their importance in cardiac regeneration and repair. As their altered expression affects cardiac function, miRs and lncRNAs could be potential targets for therapeutic intervention. In this context, miR- and lncRNA-based gene therapies are an interesting field for harnessing the complexity of ncRNA-based therapeutic approaches in cardiac diseases. In this review we will focus on lncRNA- and miR-driven regulations of cardiac development and repair. Finally, we will summarize miRs and lncRNAs as promising candidates for the treatment of heart diseases.

Interactions between microRNAs and long non-coding RNAs in cardiac development and repair

Pozzo, Enrico
Writing – Original Draft Preparation
;
Sampaolesi, Maurilio
Writing – Original Draft Preparation
2018-01-01

Abstract

Non-coding RNAs (ncRNAs) are emerging players in muscle regulation. Based on their length and differences in molecular structure, ncRNAs are subdivided into several categories including small interfering RNAs, stable non-coding RNAs, microRNAs (miRs), long non-coding RNAs (lncRNAs), and circular RNAs. miRs and lncRNAs are able to post-transcriptionally regulate many genes and bring into play several traits simultaneously due to a myriad of different targets. Recent studies have emphasized their importance in cardiac regeneration and repair. As their altered expression affects cardiac function, miRs and lncRNAs could be potential targets for therapeutic intervention. In this context, miR- and lncRNA-based gene therapies are an interesting field for harnessing the complexity of ncRNA-based therapeutic approaches in cardiac diseases. In this review we will focus on lncRNA- and miR-driven regulations of cardiac development and repair. Finally, we will summarize miRs and lncRNAs as promising candidates for the treatment of heart diseases.
2018
Esperti anonimi
Inglese
Internazionale
ELETTRONICO
127
58
66
9
Cardiac development and repair; Exosomes; MiRs and lncRNAs; NcRNA-based therapies; Pharmacology
http://www.elsevier.com/inca/publications/store/6/2/2/9/3/1/index.htt
4
info:eu-repo/semantics/article
262
Rotini, Alessio; Martínez-Sarrà, Ester; Pozzo, Enrico; Sampaolesi, Maurilio
1 Contributo su Rivista::1.1 Articolo in rivista
open
File in questo prodotto:
File Dimensione Formato  
Rotini et al Pharm Res 2018.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: DRM non definito
Dimensione 1.29 MB
Formato Adobe PDF
1.29 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1211512
Citazioni
  • ???jsp.display-item.citation.pmc??? 29
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 47
social impact